chrisvoncsefalvay/vaers-outcomes huggingface dataset:
no adverse event; They received their first dose last year (06Aug2022) and never got the second dose of the monovalent vaccine.; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (They received their first dose last year (06Aug2022) and never got the second dose of the monovalent vaccine.) and NO ADVERSE EVENT (no adverse event) in a 5-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     HCP stated they are unaware of any medical hIstory or condition.     On 06-Aug-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Aug-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (They received their first dose last year (06Aug2022) and never got the second dose of the monovalent vaccine.). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (They received their first dose last year (06Aug2022) and never got the second dose of the monovalent vaccine.) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for PRODUCT ADMINISTRATION INTERRUPTED (They received their first dose last year (06Aug2022) and never got the second dose of the monovalent vaccine.).    Patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine were unknown. Concomitant medication details not reported by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
The week after my booster shot, I had severe excruciating pain in my face that came on suddenly and continues to come on suddenly when eating. It feels like a hot bolt, and is very debilitating. I then went to a neurologist and was diagnosed with trigeminal neuralgia. I am still getting tests done and they have given me new medications since symptoms are still coming and going. The medication that I was given is helping however there are days that the symptoms come on suddenly. I also have dizziness spells and overall fatigue since having my vaccines.
The pt states that she woke up during the night with sweats, dizziness, entire right arm sore with tingling in fingers, tenderness at injection site. Generalized hives during evening, treated with Benadryl. States was also on an antibiotic, sulfite at the time of adverse reaction.
With GARDASIL #1, had minimal facial swelling. After GARDASIL #2, about 1 hour after vaccine, developed swelling of face and swelling of both eyes. Swelling decreased the next day but still had some mild periorbital swelling then. No other symptoms.
Feeling weak, nausea, headache. After taking a nap woke up and had a migraine. Stated s/s developed 07/19/2014 and has not reported until 07/24/2014.
Information has been received from a nurse concerning a 12 month old female patient who on 10/1/99 was vaccinated SC into the right arm with a first dose of MMR (second generation) (lot # 632326/0939J). Concomitant therapy on 10/1/99 included a first dose of varicella virus vaccine live (lot # 631170/0731J) SC into the left arm and a third dose of poliovirus vaccine (lot # N1061-2) Sc into the left leg. The reporter indicated that the patient fell off her tricycle at day care on 10/13/99. it was reported that the patient had a split lip and a few bruises. On 10/14/99 the patient's mother called the doctors office at 06:30 am. The patient had many petechiae and was somewhat listless but had no fever or other symptoms. The patient was referred to a hospital emergency room for evaluation. It was reported that the patient's bruises were consistent with the described fall. A CBC showed platelets 20K, WBC 5K with ANC of 300 and a HGB of 12.5. It was noted that an IV line was placed and blood cultures obtained and the patient received a dose of ceftriaxone. It was reported that the patient was transferred to the pediatric ICU. The reporter was unsure of the length of the patient's hospital stay. A bone survey of the head and CT of the head were within normal limits. Additional lab findings included a CBC which showed platelets of 89K and absolute neutrophils 583 (1500-8500). The patient was referred to a hematologist. The reporter indicated that the patient was diagnosed with thrombocytopenia due to low platelet levels. It was unknown if the patient was treated for the thrombocytopenia. The nurse stated that the physician felt that it was idiopathic thrombocytopenia purpura. It was reported that the patient had ITP secondary to MMR or VZV vaccine. Treatment plans included a helmet and titers before considering repeat MMR. The patient was seen in the office on 10/18/02 and 10/27/02 for follow up lab work. On 10/29/02 it was noted that the patient was recovering from ITP. She was noted to have neutropenia at that time, which the physician noted was probably viral associated. The nurse noted that the patient did not recover completely and that she saw the patient the other day and she was doing well. It was reported that the patient had antibodies to measles and rubella and that the titers were up. Additional information is not expected.
At first nothing but muscle soreness at the site, but I woke up soon after going to bed feeling nauseated almost threw up, also felt drunk (balance, lack of clear thinking, a little weak, etc). That lasted from about 8 hours after the shot (when it started) to 20 hours after the shot was administered.
Big hives that itches about half an inch away where I got the vaccine; Big hives that itches about half an inch away where I got the vaccine; This is a spontaneous report from a contactable consumer or other non-health professional (patient). A patient of unspecified age and gender received bnt162b2 (BNT162B2, formulation: solution for injection, lot number: ER8727, expiry date: not reported), via an unspecified route of administration on 18Mar2021 as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced big hives that itches about half an inch away where patient got the vaccine. Patient did not saw anything on the paper that says you could get hives so much (intent not clarified, hence MI not documented). The patient stated, "No, all I know is that I got an injection yesterday and just about a "quarter of an inch" (not clarified) away I have a big hives that is itching, about a quarter of an inch. Clinical outcome of the events was reported as unknown.  No follow-up attempt are possible. No further information expected.
Received Moderna vaccines on 1/7, 2/4/21 Tested positive for COVID by PCR on 12/13/21 Admitted to local HCF on 12/14/21 d/t pulmonary infiltrates, fatigue, diarrhea, and hypoxia.
Patient was here to receive his 2nd Pfizer COVID injection.  Pfizer wasn't available and he stated he would take the Moderna..The injection was given to him not realizing that he was 16 y.o. Patient had no adverse reaction.  He waited at the pharmacy for 15 min. and stated that he felt well and left..
Information has been received from a nurse, referring to a male patient of unknown age. Information about medical history, concurrent condition and concomitant therapy was unknown. On an unknown date, the patient was vaccinated with childhood dose of PROQUAD (dose, strength, route, lot# and expiration date were unknown) for prophylaxis. On an unknown date, the patient experienced an unspecified cancer. The patient had sought medical attention and received unspecified chemotherapy for his cancer. On an unknown date, at the age of 16 year old, the patient received another dose of PROQUAD. The outcome of the cancer was unknown. The causality assessment was not provided by the reporter. Upon internal review, the cancer determined to be medically significant.
Pt. states that on 7/15/05 she began to feel generalized muscle pain with increasing intensity since.  She reports today that she cannot drive, open doors, etc, and feels very bad.  She also states that she began with a mild sore throat today.  Patient denies any joint pain, fever, or rashes.  I advised patient to see her PCP ASAP.
Fatigue; Dizziness; Light temperature; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), DIZZINESS (Dizziness) and BODY TEMPERATURE INCREASED (Light temperature) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ARFORMOTEROL TARTRATE (BROVANA) and BUDESONIDE for an unknown indication.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced FATIGUE (Fatigue), DIZZINESS (Dizziness) and BODY TEMPERATURE INCREASED (Light temperature). At the time of the report, FATIGUE (Fatigue), DIZZINESS (Dizziness) and BODY TEMPERATURE INCREASED (Light temperature) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.  This case concerns an 82-year-old female with serious unexpected events of dizziness, fatigue, and temperature increased. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: This case concerns an 82-year-old female with serious unexpected events of dizziness, fatigue, and temperature increased. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Pt vaxed w/1st dose of Hep B (recomb) OCT90; W/in a few days devl URI which consisted of a cough, congestion, fever & myalgias; tx erythromycin & gradually recovered;
adverse events: multiple joint swelling, redness and pain, plus bilat led edema Treatment: steroids oral and injected, Outcome: improvement at first but wrist pain and swelling came back requiring injections
Pt had BBP exposure, Hep B titre drawn, below threshold so 2nd Hep B series started 5/27/11, no problem with vaccine. 6/24/11 2nd Hep B injection done about 230pm. 2 hours later pt developed pain at site that lasted until next morning, then area became swollen, itchy, reddened. Currently 120 cm x 160 cm warm erythematous area on (R) upper arm.
warmth in injection site; slept from 4pm to noon of the next day; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE and VACCINATION SITE WARMTH in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027H21B, 040B21A, and 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included Type 2 diabetes mellitus.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Dec-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SOMNOLENCE. On an unknown date, the patient experienced VACCINATION SITE WARMTH. On 05-Dec-2021, SOMNOLENCE had resolved. At the time of the report, VACCINATION SITE WARMTH outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was on a long list of unknown medication and did not take anything on the day when she took booster and the day after. Treatment information was unknown.
Pt was vaccinated without issue. Pt advised to sit for 15 mins.  After being in observation area for 5 mins, pt stood up and immediately fainted and fell to the floor hitting head on floor.  Pt had some bleeding from small laceration on head.  9:50am VS BP 130/80, P 60.  Rescue called and was brought to ED for evaluation since he hit his head.
Benadryl 125mg. Today, history of swelling at site of immunization on left arm. Started next day after received shots; no fever. History of similar reaction in thigh when received vaccine according to mom; some itching, no other swelling.
other zoster-related conditions; shingles; Information has been received from a lawyer, regarding a case in litigation, and refers to a patient (pt) of unknown age and gender. No information about the pt's medical history, concurrent conditions or concomitant medications was provided. On an unknown date in 2014, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiration date were not provided) by a pharmacist at a pharmacy for the long-term prevention of shingles and zoster-related conditions. On unknown dates, subsequently to the pt's zoster vaccine live (ZOSTAVAX) inoculation, the pt was treated by a physician for shingles and other zoster-related conditions. As a direct and proximate result of the pt's use of zoster vaccine live (ZOSTAVAX), the pt had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of the events was considered not recovered/not resolved (reported as would continue suffer ongoing injuries). The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).
This spontaneous report was received on 30-JUN-2017 from a physician via a company representative regarding an 18-year-old patient (gender not reported). Medical history, concurrent conditions, concurrent medications, and allergies were not reported. The physician had reported to the field representative that the 18-year-old patient was inadvertently administered an adult dose of VAQTA (dose, route of administration, site of administration, Lot number and expiration date were not reported). The indication was not reported. It was not further reported if the patient was to receive the pediatric formulation but was inadvertently administered an adult dose of VAQTA. No adverse effect reported. Additional information has been requested.
Redness and swelling at site - upper right arm.  Inner redness 4cm x 6cm, outer redness 15cm x 12cm.
Developed fever Friday night and continued with fever up to 104.5 Saturday, Sunday, and Monday. 102.6 Tuesday. Fussy at times, playful when fever decreased, appetite poor. Fever resolved 1/16/04.
Patient said about week after the shot, he didn't feel right and went to local urgent care, said the provider told him he had Bell's Palsy on left side.
Site: Itching at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Fever-Mild, Additional Details: Patient has reported round-shaped redness, warmth, and itching around the injection site since 10/19/2021 at approximately 9:00pm. Since then, the patient stated that the symptoms have improved. The patient is counseled to seek medical attention if desired.
Caller then caught covid in July; first two covid 19 vaccines they started to have symptoms from the brain disorder; Caller got the first booster dose the following September and got twice the amount; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Caller then caught covid in July), CEREBRAL DISORDER (first two covid 19 vaccines they started to have symptoms from the brain disorder) and ACCIDENTAL OVERDOSE (Caller got the first booster dose the following September and got twice the amount) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.   In February 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2020, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In September 2020, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In June 2022, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (Caller then caught covid in July), CEREBRAL DISORDER (first two covid 19 vaccines they started to have symptoms from the brain disorder) and ACCIDENTAL OVERDOSE (Caller got the first booster dose the following September and got twice the amount). At the time of the report, COVID-19 (Caller then caught covid in July), CEREBRAL DISORDER (first two covid 19 vaccines they started to have symptoms from the brain disorder) and ACCIDENTAL OVERDOSE (Caller got the first booster dose the following September and got twice the amount) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter.  Reportedly, reporter had heard in people his age of being 30 that there was a risk of myocarditis and wondering if there was a potential of an increased risk of getting that with the Moderna Bivalent. It was reported that patient was getting surgery for his condition in January for his brain disorder that has already before patient had the vaccine.  Treatment details were not reported by the reporter.
Vial was refrigerated after 30-day use by date; Vaccine administered to patient after 30-day use by date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered to patient after 30-day use by date) and PRODUCT STORAGE ERROR (Vial was refrigerated after 30-day use by date) in a 3-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1416B) for COVID-19 prophylaxis.     It was unknown if patient was diagnosed with COVID-19 in the past. Patient did not had any allergies. It was unknown if other vaccines were given within one month prior to Moderna COVID-19 vaccine.     On 21-Jul-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered to patient after 30-day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was refrigerated after 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered to patient after 30-day use by date) and PRODUCT STORAGE ERROR (Vial was refrigerated after 30-day use by date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information provided.  It was reported that on 21-Jul-2022 patient had administered Moderna Infant Vaccine Lot AS1416B received on 20-Jun-2022 and was expired after 30 day use by date on 20-Jul-2022. Vaccine was stored in a refrigerated state within the required temperature entirely.  It was unknown if AE caused patient to seek medical care. It was unknown if patient had experienced any similar event in the past.  No treatment information provided.
Rash around injection site Rash around neck Migraines Nausea  Fever Ache
10/31/2021 Most pronounced symptom I had was fatigue, followed by a headache then chills. This lasted about 24 hours. I also had a little it of achiness.
have this weird symptom that started 10/6. my left arm pit stared to get sore, then swollen, and is now so tender i couldnt sleep and can barely let my arm rest at my side. it is the arm that got the injection. maybe lymph nodes? the outside of my arm is tender as expected but the arm pit and my left breast is where it has settled
12MAY pt fever 102-103, cranky & cross; 14MAY rash generalized both eyes matted; 17MAY seen by CNP dx'd BOM, conjunctivits, bronchitis; 20MAY mom says child much better;
Systemic: Flushed / Sweating-Mild, Additional Details: patient said she was prone to passing out from anxiety of getting vaccines and within 3 minutes of receiving vaccine patient said she felt like she was going to pass out and did seem to black out for a few seconds. 911 was called but patient refused treatment and was fully recovered before leaving EMT recommended patient take antiaxiety medication before receiving another vaccine
The following day 1/29/2021, I started with chills and then later night sweats.  I also had headaches.  Saturday1/30/2021, I had muscle pain and joint pain throughout my body most notably in my right knee and right hip.  Today, Monday 2/1/2021, my rib cage is sore with muscle pain.
PT succumbed to COVID-19 after diagnosis on 8/10/21 during nursing home outbreak. Pt was hospitalized on 8/13/21
Information has been received from a nurse concerning a 12 or 13 year old female who in August 2007 (date unknown), was vaccinated with the 1st dose of HPV rL1 6 11 16 18 VLP vaccine (yeast).  The nurse reported that the patient fainted at the check out window as she was leaving the office.The patient's vital signs were checked and the patient was monitiered for approximately 30 minutes. The patient was alert and oriented prior to leaving th office. The nurse stated that the GARDISIL therapy was discontinued. No additional information is expected.
Pt received Dtap and Hib right thigh, IPV and Prevnar left thigh, within 10" both legs markedly erythematous. Erythema left resolved in <10" but erythema, warmth and swelling increased on right and was from thigh to toes. On the following day pt had petechial of left thigh.
Symptoms started about 10:00 PM on Saturday, 5-20-23.  I felt cold and began shivering badly.  I crawled under the blanket and, several minutes later, the shivering stopped.  I woke up every 15-20 minutes throughout the night because of mild aches.  Whenever I had to go to the bathroom the cold and shivering started again.  The symptoms slowly decreased in the early morning.  because of lack of sleep, I was tired for the next two days.
High Dose influenza vaccine was inadvertently given to a 28 year old nurse by a staff nurse. There were no effects noted by the recipient.
Pt was administered routine 4 year old vaccines and developed rash and itching approx 5-10 mins after vaccination. pediatrician was notified and was instructions received to give Benadryl.
14 hours after my second dose I became nauseous and threw up yellow bile intermittently (about 5 separate times, each retching fit lasting 5 minutes) until 12:30pm. My primary care physician prescribed Zofran helped curb the vomiting. I also had a fever of 103.1 for half an hour before it subsided to 100, body aches, sweating, chills, headache, and nausea. Today, 4/28 over 24 hours after my vaccine, I started presenting a swelling on my right hand that is itchy and discolored, although the side effects from the day before have lessened to a certain degree.
Swelling and redness at injection site with itching of skin on trunk and other extremities.  Zyrtec for itching.